Research view
Switch to patient viewMultiple myeloma: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target to see only the groups that work on it.
- All targets
- BCMA 134
- CD38 22
- GPRC5D 36
- CD19 31
- TP53 0
- STAT3 0
- CXCR4 4
- MYC 0
- BCL-2 2
- PI3K 1
- mTOR 0
- IL-6 0
- STING 0
- BRAF 2
- CD47 1
- HDAC 0
- AKT 0
- PD-1 1
- PD-L1 1
- CD20 3
- GLP-1 0
- JAK 0
- PTEN 0
- SGLT2 0
- AMPK 0
- B7-H3 0
- NRAS 1
- TIGIT 0
- CTLA-4 1
- ERK 0
- EZH2 0
- FTO 0
- IL-15 3
- JNK 0
- KRAS 1
- MAPK 0
- RAS 0
- CD22 2
- CD33 1
- CTNNB1 0
- EGFR 0
- FGFR 0
- LAG-3 0
- MDM2 0
- METTL3 0
- NRF2 0
- BRCA1 0
- BRD4 0
- BTK 1
- CD123 1
- CD30 0
- CDK4/6 0
- GPX4 0
- HER2 0
- HIF-1 0
- HSP90 0
- MEK 0
- MET 0
- MUC1 0
- NTRK 0
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
Targeting EP300/CBP in AML: from mechanistic discovery to therapeutic innovation (EPIC-AML)
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-ERC
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-ERC
European Commission (Horizon Europe) · HORIZON-RIA
iNK Cell–Driven Strategies for Enhanced Multiple Myeloma ImmunotherapY (iN-KEY)
European Commission (Horizon Europe) · HORIZON-RIA
A CEllulaR immunoTherapy virtuAl twin for personalIsed cancer treatmeNT (CERTAINTY)
5 of 7 running projects, newest first. Listed amounts together: €35.6m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
No trial in this view states that it shares participant data.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 23
- Organoids 3
- Mendelian Randomization Analysis 10
- CRISPR-Cas Systems 8
- Gene Expression Profiling 44
- Sequence Analysis, RNA 7
- Whole Genome Sequencing 4
- Exome Sequencing 3
- Proteomics 15
- Metabolomics 10
- Mass Spectrometry 7
- Flow Cytometry 48
- Immunohistochemistry 11
- Liquid Biopsy 2
- Circulating Tumor DNA 2
- Xenograft Model Antitumor Assays 78
- Positron-Emission Tomography 14
- Magnetic Resonance Imaging 26
- Machine Learning 17
- Deep Learning 6
- Cohort Studies 32
- Genome-Wide Association Study 7
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.